Navigation Links
Stem Cell Markets - New Market Report
Date:11/5/2013

lls 279
Appendix 2.8.2: RPE and Photoreceptor Diseases 279
Appendix 2.8.3: Pluripotent Stem Cells for Retinal and RPE Degeneration 280
Appendix 2.8.4: Patch of hESC-Derived RPE Monolayer 280
Appendix 2.8.5: Patient-Derived RPE 280
Appendix 2.8.6: NSCs for AMD 281
Appendix 2.8.7: UCSCs for RP and AMD 281
Appendix 2.8.8: Bone Marrow Stem Cells for Photoreceptor Diseases 281
Appendix 2.8.9: Corneal Repair 281
Appendix 3: RM Clinical Milestones in the News, March 2012-March 2013 282
Appendix 4: Financial Overview of RM Sector 285
Appendix 4.1: Sector Activity 285
Appendix 4.2: Public Company Performance 286
Appendix 4.3: RM Financial News and Commercial Deals, 2012-2013 288
Appendix 5: Top 50 Stem Cell Influencers in Stem Cells Arena 294

INDEX OF FIGURES

Figure 2.1: Differentiation of Stem Cells into Adult Differentiated Cells 20
Figure 2.2: Pluripotent Embryonic Stem Cell 21
Figure 2.3: Induced Pluripotent Stem Cell (iPSC) 22
Figure 2.4: Differentiation of Stem Cells into Specialized Cells 23
Figure 2.5: Clinical Trials Using MSCs by Disease Type 27
Figure 2.6: Induction and Differentiation of iPSCs 31
Figure 3.1: Outline of Drug Discovery Process 33
Figure 3.2: The Development of Totipotent, Pluripotent and Multipotent Stem Cells 34
Figure 4.1: Number of Cell Therapy Clinical Trials (Total 226) by Geography, 2012 41
Figure 4.2: Number of Cell Therapy Clinical Trials by Top Ten Countries, 2012 42
Figure 4.3: Cell Therapy Clinical Trials by Type of Sponsorship, 2012 43
Figure 4.4: Cell Therapy Clinical Trials by Cell Type, 2012 44
Figure 4.5: Cell Therapy Clinical Trials by Stem Cell Type, 2012 45
Figure 4.6: Stem Cell Therapy Clinical Trials Involving Non-Stem Cells, 2012 46
Figure 4.7: Cell Therapy Involving MSCs by Source, 2012 47
Figure 4.8: Clinical
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. Biosimulation Market (For Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
2. Geosynthetics Market (Geotextile, Geomembrane, Geogrid, Geofoam, Geonet) Volume Worth 5.6 Billion Meter Square by 2018 - New Report by MarketsandMarkets
3. Customer Experience Management Market (Network Types, Touch Points, Verticals) Worth $6.61 Billion by 2017 - New Report by MarketsandMarkets
4. Bring-Your-Own-Device Market (Mobile Device Management, Mobile Application Management) Worth $181.39 Billion by 2017 - New Report by MarketsandMarkets
5. Pressure Sensor Market (Piezoresistive, Capacitive, Electromagnetic, Resonant Solid State, Optical) Worth $7.34 Billion by 2017 - New Report by MarketsandMarkets
6. Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI) Worth $5 Billion - 2017 - New Report by MarketsandMarkets
7. Biofuels (Bioethanol & Biodiesel) Production in Top and Emerging Countries will be 150,975 Million Liters in 2016 - New Report by MarketsandMarkets
8. Acoustic Wave Sensor Market (SAW And BAW) Worth $721.13 Million - Global Forecast by 2018 - New Report by MarketsandMarkets
9. Cloud Radio Access Network (CLOUD RAN) Market (Components and Services) worth $11.31 Billion by 2018 - New Report by MarketsandMarkets
10. Infection Control Market (Sterilization and Disinfection) Worth $14.0 Billion by 2017- New Report by MarketsandMarkets
11. Aqua Feed Market (Antibiotics, Vitamins, Antioxidants, Amino Acids, Feed Enzymes, Feed Acidifiers) Worth $106 Billion By 2018 - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... MD, April 22, 2014: The Association for Molecular ... The Journal of Molecular Diagnostics on recommendations ... baccalaureate and master,s levels of education. The report ... Curriculum Task Force of the AMP Training and ... critical need of educating future medical laboratory scientists ...
(Date:4/22/2014)... German . ... but their mode of action is complex: In low ... behavior, while at high concentrations they can cause "oxidative ... how redox signaling unfolds in single cells and organelles ... developed jointly by the teams of LMU Professor Martin ...
(Date:4/22/2014)... we all seem to know who we say is neurotic ... isn,t unable to act but simply doesn,t want to., ... study of nearly 4,000 college students in 19 countries has ... decisions and moving forward with life. Turns out that when ... just don,t like it as much as non-neurotics. Therefore persuasive ...
(Date:4/22/2014)... This news release is available in German . ... F. Perutz Laboratories of the University of Vienna and the ... Zurich, have now shown how double stranded RNA, such as ... a cell. During the immune response against viral infection, the ... cytoplasm. There it modifies viral RNA to inhibit reproduction of ...
(Date:4/22/2014)... like toddlers, but their total brain size suggests ... or fox squirrel, according to a new study ... from orangutans to zebra finches. , Scientists at ... than two-dozen other research institutions collaborated on this ... defined in the study as the ability to ...
Breaking Medicine News(10 mins):Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:Neuroimaging: Live from inside the cell 2Health News:Neurotics don't just avoid action: They dislike it 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3
... MedCom USA, Inc.,(OTC Bulletin Board: EMED), a leading ... for the healthcare industry,has signed a distribution agreement ... force, the product line of MedCom USA.,MedCom,s products ... options which include Credit/Debit, Easy Pay and Check,Guarantee/EFT ...
... Heart Association says high blood sugar condition linked to ... -- A national effort is needed to deal with ... says an American Heart Association scientific statement released Monday. ... about the condition, also known as hyperglycemia, in people ...
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... president of clinical research. In this newly,created position, ... and,oversight of Rigel,s clinical research programs in rheumatoid ... syk kinase,inhibitor, is expected to enter advanced Phase ...
... /Xinhua-PRNewswire-FirstCall/ -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS; ... the United States that operates Beijing Liang,Fang Pharmaceutical ... Pharmaceutical,Co., Ltd. both of which are pharmaceutical companies ... that it has raised $5 million in,a private ...
... NEW YORK, Feb. 26 , WHO: New York Lt. Gov. David A. Paterson, along with stem ... R. Lyon, M.D., will be the keynote speakers at the 3rd ... p.m. on Tuesday, February 26 ... Trianon Ballroom 1335 Avenue ...
... BMR, TORONTO, Feb. 26 /PRNewswire-FirstCall/ ... dedicated to the development and,commercialization of ... II data,on the Company,s Neuradiab product ... glioblastoma multiforme (GBM) were published in ...
Cached Medicine News:Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 2Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 3Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 4Health News:National Effort Needed to Address Hyperglycemia in Heart Patients 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 3Health News:Lotus Pharmaceuticals Raises $5 Million in Private Placement 2Health News:Lotus Pharmaceuticals Raises $5 Million in Private Placement 3Health News:MEDIA ADVISORY: New York Lt. Gov. David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 3Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 4
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Ga., May 3, 2011 Precyse , ... and technologies, announces the general availability of ... information management platform available today. PrecyseCode is driven ... voice, converting it to text and transforming it ...
... May 3, 2011 HistoRx, Inc., announced today ... researchers interested in using AQUA® technology.  HistoRx,s proprietary ... biomarkers, including measurement of protein concentration with sub-cellular ... microarrays.  These highly quantitative, standardized and reproducible results ...
Cached Medicine Technology:Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 2Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 3Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 4Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 5Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management 6HistoRx Announces Launch of New Research Services: AQUAPrep™ and Access AQUA® Services Now Available 2HistoRx Announces Launch of New Research Services: AQUAPrep™ and Access AQUA® Services Now Available 3
... The VersaPulse® PowerSuite™ holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
... adjustable height permits optimal leg position for the ... a cast with the foot/ankle at 90 degrees ... the tongue of the stand. Stockinette is pulled ... plaster/fiberglass is used in a routine fashion. The ...
... Techno-Aide provides the highest level of ... quality lead protective eyewear. Consistent ... tolerance allowed. Mfg supervised by Licensed ... lens meet or exceed standards for ...
Medicine Products: